| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/10/2009 | US7488710 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 02/10/2009 | US7488588 Compounds related to or derived from GFR α4 and their use |
| 02/10/2009 | US7488494 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 02/10/2009 | US7488491 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 02/10/2009 | US7488487 Administering an auxotropic attenuation strain of Listeria which expresses an antigen; induction immunology response; anticancer agents |
| 02/10/2009 | CA2389709C Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 02/10/2009 | CA2380904C Nsaid and efgr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer |
| 02/10/2009 | CA2339299C Method of modulating memory effector t-cells and compositions |
| 02/10/2009 | CA2328396C New substituted amides, their production and their use |
| 02/10/2009 | CA2294098C Novel thyroid receptor ligands and method |
| 02/10/2009 | CA2211270C Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 02/05/2009 | WO2009018551A2 Therapeutic compounds |
| 02/05/2009 | WO2009018549A1 Therapeutic compounds |
| 02/05/2009 | WO2009018505A1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 02/05/2009 | WO2009018429A2 TREATMENT OF CANCER VIA TARGETING OF IL-13 RECEPTOR-α2 |
| 02/05/2009 | WO2009018411A1 Human antibodies to human cd20 and method of using thereof |
| 02/05/2009 | WO2009017838A2 Combinations of jak-2 inhibitors and other agents |
| 02/05/2009 | WO2009017833A2 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 02/05/2009 | WO2009017822A2 Pi3 kinase modulators and methods of use |
| 02/05/2009 | WO2009017795A1 Indazole compounds for treating inflammatory disorders, demyelinating disorders and cancers |
| 02/05/2009 | WO2009017701A2 Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment |
| 02/05/2009 | WO2009017394A1 Substituted cc-1065 analogs and their conjugates |
| 02/05/2009 | WO2009017219A1 Inhibitor of binding of s1p1 |
| 02/05/2009 | WO2009016647A1 Pyrrolo [2,1-c][1, 4] benzodiazepine-glycoside prodrugs useful as a selective anti tumor agent |
| 02/05/2009 | WO2009016498A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions |
| 02/05/2009 | WO2009016460A2 Pyrazole compounds and their use as raf inhibitors |
| 02/05/2009 | WO2009016286A2 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/05/2009 | WO2009016164A1 Novel antibodies |
| 02/05/2009 | WO2009016132A1 Pyrrolopyrimidines |
| 02/05/2009 | WO2009016072A2 A morpholinyl anthracycline derivative combined with protein kinase inhibitors |
| 02/05/2009 | WO2009016031A1 Oxidized avidin with high residency time in the treated tissues |
| 02/05/2009 | WO2009015981A2 Treatment of pediatric tumors |
| 02/05/2009 | WO2009015867A1 Substituted aryl or heteroarylpiperdine derivatives as melanocortin-4 receptor modulators |
| 02/05/2009 | WO2009015843A1 Novel immunotherapy against neuronal and brain tumors |
| 02/05/2009 | WO2009015841A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | WO2009015602A1 Polypeptides having anticancer activity |
| 02/05/2009 | WO2009015491A1 Umps isoforms as novel predictive markers and therapeutic targets for chemotherapeutics |
| 02/05/2009 | WO2009015485A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/05/2009 | WO2009015447A2 Polyacetal-carboxylic acids in the treatment of cancer and auto-immune disorders |
| 02/05/2009 | WO2009000168A1 An antrodia camphorata cyclohexenone compound used for decreasing physiological fatigue |
| 02/05/2009 | WO2008144223A3 Triazolyl aminopyrimidine compounds |
| 02/05/2009 | WO2008137207A3 Inactivators of o6-alkylguanine-dna alkyltransferase |
| 02/05/2009 | WO2008124703A3 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry |
| 02/05/2009 | WO2008108986A3 Methods and compositions for treating tumor diseases |
| 02/05/2009 | WO2008076939A3 Human cancer therapy using engineered matrix metalloproteinase-activated anthrax lethal toxin that targets tumor vasculature |
| 02/05/2009 | WO2008065637A9 Treatment of disease |
| 02/05/2009 | WO2003099808A8 Substituted heterocyclic compounds and methods of use |
| 02/05/2009 | US20090036761 Noninvasive measurement of chemical substances |
| 02/05/2009 | US20090036544 Methods and compositions for inhibiting the proliferation of prostate cancer cells |
| 02/05/2009 | US20090036540 Guanylhydrazones in Methods of Treatment or Diagnosis as Modulators of Signal Transduction |
| 02/05/2009 | US20090036519 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 02/05/2009 | US20090036517 Anti-angiogenic compositions and methods of use |
| 02/05/2009 | US20090036508 Amino indazole derivatives |
| 02/05/2009 | US20090036507 Bis (cyanophenyl) methyl-triazole for use in prevention of breast cancer |
| 02/05/2009 | US20090036485 Quinoline derivatives |
| 02/05/2009 | US20090036451 Chemical inducers of neurogenesis |
| 02/05/2009 | US20090036449 Indazolesquaric Acid Derivatives as Chk1, Chk2 and Sgk Inhibitors |
| 02/05/2009 | US20090036445 Kinase inhibitors |
| 02/05/2009 | US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/05/2009 | US20090036441 Indole Derivatives With Antitumor Activity |
| 02/05/2009 | US20090036440 Novel pyrimidine derivatives - 816 |
| 02/05/2009 | US20090036435 Pharmaceutical Compounds |
| 02/05/2009 | US20090036431 Cytotoxic Agents Comprising New Tomaymycin Derivatives |
| 02/05/2009 | US20090036429 Hydroxypiperidine Derivatives and Uses Thereof |
| 02/05/2009 | US20090036419 Compounds useful as raf kinase inhibitors |
| 02/05/2009 | US20090036418 Pharmaceutical composition for treatment of cancer containing pyridylpyridazine or transition metal complex thereof as active ingredient |
| 02/05/2009 | US20090036412 Methods and Compositions for Inhibition of Angiogenesis |
| 02/05/2009 | US20090036411 Modulation of cell fates and activities by phthalazinediones |
| 02/05/2009 | US20090036410 Structured Phospholipids |
| 02/05/2009 | US20090036406 Injection |
| 02/05/2009 | US20090036392 Composition comprising biodegradable hydrating ceramics for controlled drug delivery |
| 02/05/2009 | US20090036391 Modulation of line-1 reverse transcriptase |
| 02/05/2009 | US20090036390 Compositions and methods for treating neoplastic diseases |
| 02/05/2009 | US20090036387 Novel chemical entities affecting neuroblastoma tumor-initiating cells |
| 02/05/2009 | US20090036380 Composition And Method For Brain Tumor Therapy |
| 02/05/2009 | US20090036378 Use of Factor VIIa or a Tissue Factor Antagonist for Regulating Gene Expression and Cell Migration or Chemotaxis |
| 02/05/2009 | US20090036374 Hepatocyte growth factor receptor splice variants and methods of using same |
| 02/05/2009 | US20090036369 Anti-tumor agents comprising r-spondins |
| 02/05/2009 | US20090036368 Therapeutic Combination |
| 02/05/2009 | US20090036360 Medicament containing activated antithrombin iii |
| 02/05/2009 | US20090036309 Oxabicycloheptanes and oxabicylcoheptenes, their preparation and use |
| 02/05/2009 | US20090035771 gene expression; probes, primers, antibodies |
| 02/05/2009 | US20090035403 Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof |
| 02/05/2009 | US20090035395 Spondias mombin l. extract and methods of extracting and using such extract |
| 02/05/2009 | US20090035394 Use of dna-pk inhibition to sensitise atm deficient cancers to dna-damaging cancer therapies |
| 02/05/2009 | US20090035389 Targeted protein cages |
| 02/05/2009 | US20090035371 Tablet with remedial composition and methods for treating medical disorders and ailments |
| 02/05/2009 | US20090035343 Subcutaneously implanting a device containing octreotide and hydroxpropylcellulose encased in a hydrophilic addition copolymer., e.g., hydroxyethyl- hydroxypropyl methacrylate; delivers octreotide over 6 months at a controlled rate to avoid the suffering of multiple periodic injections. |
| 02/05/2009 | US20090035317 Peptides binding to vascular endothelial growth factor |
| 02/05/2009 | US20090035316 Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC) |
| 02/05/2009 | US20090035312 Tumor angiogenesis associated genes and a method for their identification |
| 02/05/2009 | US20090035311 Identification and use of prognostic and predictive markers in cancer treatment |
| 02/05/2009 | US20090035310 Cancer treatment |
| 02/05/2009 | US20090035309 Substituted Benzazoles and Methods of Their Use as Inhibitors of RAF Kinase |
| 02/05/2009 | US20090035301 Methods for diagnosing and treating bladder cancer |
| 02/05/2009 | US20090035300 Immunomodulation of dendritic cells |
| 02/05/2009 | US20090035299 Methods and compositions for treating diseases targeting MABA1 |
| 02/05/2009 | US20090035292 Use of phosphatases to treat neuroblastomas and medulloblastomas |
| 02/05/2009 | US20090035290 Glycine N-methyltransferase (GNMT) Animal model and use thereof |
| 02/05/2009 | US20090035281 Combination of interleukin-6 antagonists and antiproliferative drugs |